U.S. Electronic Equipment and Components Stock News

Pinnacle Financial Partners, Inc. has already reported first‑quarter 2026 results, with net income rising to US$150 million from US$140 million a year earlier, while basic and diluted earnings per share from continuing operations fell to US$0.89 from about US$1.78 and US$1.77, respectively. This combination of higher total profit but sharply lower per‑share earnings, alongside AI-driven trading showing mixed time‑horizon sentiment, adds complexity to how investors may interpret Pinnacle’s...

AnaptysBio recently reported that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim over their Jemperli collaboration, while CEO Daniel Faga is set to discuss the company’s royalty assets at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. This legal outcome, combined with a stronger earnings outlook highlighted by an upgraded Zacks rank, strengthens AnaptysBio’s position around its Jemperli-related royalty rights. We’ll now...

In the first quarter of 2026, Molson Coors Beverage Company reported year-on-year increases in sales to US$2,717.9 million, revenue to US$2,351.1 million, and net income to US$151.3 million, with basic earnings per share from continuing operations rising to US$0.80. The company coupled these stronger results with a three-year US$450 million cost-savings program, continued integration of Monaco Cocktails, and reaffirmed full-year 2026 guidance despite ongoing volume and cost pressures. We’ll...

AGNC Investment (AGNC) opened 2026 with a softer quarter, reporting Q1 total revenue of a loss of US$114 million and a basic EPS loss of US$0.17, set against trailing twelve month revenue of US$1.6 billion and EPS of US$1.22. Over recent periods the company has seen quarterly revenue move from US$154 million in Q4 2024 to US$995 million in Q4 2025, with basic EPS shifting from US$0.10 to US$0.83 over the same span. Trailing twelve month revenue rose from US$973 million in Q4 2024 to US$1.8...

Alphatec Holdings (ATEC) is back in focus after reporting first quarter 2026 results, with a net loss of US$33.91 million and basic loss per share of US$0.22 from continuing operations. See our latest analysis for Alphatec Holdings. At a share price of US$10.23, Alphatec Holdings has seen a 9.41% 7 day share price return but a 50.72% year to date share price decline. The 1 year total shareholder return is 15.94% lower, suggesting recent momentum has faded despite interest around the Q1 2026...

In late April 2026, The Scotts Miracle-Gro Company reported past second-quarter results showing US$1,459.5 million in sales and US$238.6 million in net income, with both basic and diluted earnings per share from continuing operations increasing year over year. Alongside these results, Scotts Miracle-Gro reaffirmed its fiscal 2026 outlook and outlined its SMG 2.0 plan targeting meaningful growth, higher margins, lower leverage, and a multi-year share repurchase program that together could...

Wondering whether Scotts Miracle-Gro at around US$60.06 is priced for a recovery or still carrying too much risk? This article focuses on what the current share price might be implying about value. The stock has been volatile recently, with a 7 day return of an 8.1% decline, a 30 day return of a 6.0% decline, and a 1 year return of 14.3%, while the 5 year return sits at a 70.3% decline. Recent headlines around Scotts Miracle-Gro have focused on the company’s position in consumer lawn and...

Why Erie Indemnity’s latest earnings and dividend matter for shareholders Erie Indemnity (ERIE) reported first quarter earnings with revenue of US$1,011.91 million and net income of US$150.47 million, alongside an approved US$1.4625 quarterly dividend per Class A share. See our latest analysis for Erie Indemnity. Erie Indemnity’s recent earnings and dividend news comes after a challenging spell for the stock, with a 30 day share price return of an 11.33% decline and a year to date share price...

The Bank of N.T. Butterfield & Son (NTB) has drawn fresh attention after first quarter results showed higher net interest income, net income and earnings per share, along with a reaffirmed dividend and completed share buyback. See our latest analysis for Bank of N.T. Butterfield & Son. The share price sits at $55.81 after a 1-day share price return of 1.92%, building on a 30-day share price return of 4.38% and a year to date share price return of 12.29%. The 1-year total shareholder return of...

Elevance Health (NYSE:ELV) is rolling out nationwide mental health access and early intervention programs through community partnerships and digital tools. The Elevance Health Foundation currently has $23 million in active grants focused on mental health initiatives across the United States. These efforts aim to connect members with earlier, community-based care that complements the company’s existing clinical programs. For investors watching NYSE:ELV, this push into broader mental health...

This article examines whether Cohen & Steers at US$69.54 is offering fair value and breaks down what the current price may be indicating about the stock. The share price is up 0.9% over the last week and 11.0% over the past month. Year to date it is up 9.4%, while the 1 year return stands at a 6.4% decline, set against a 3 year return of 42.2% and a 5 year return of 17.1%. Recent headlines have focused on Cohen & Steers in the context of the wider Capital Markets sector, with attention on...

In March 2026, ImmunityBio received an FDA warning letter over allegedly misleading promotional claims for its bladder cancer drug Anktiva, triggering multiple securities class action lawsuits that allege misrepresentation and securities fraud. At the same time, the company has reported very large year-over-year product revenue growth and accelerating global adoption of Anktiva, creating a tension between operational momentum and heightened legal and regulatory risk. We’ll now examine how...

IAC (IAC) has just posted its Q1 2026 scorecard, and the latest trailing twelve month figures show total revenue of about US$2.4 billion with a basic EPS loss of US$1.49 and net income excluding extra items of US$119.31 million in losses. Over recent quarters the company has seen quarterly revenue move from US$642 million in Q3 2024 to US$721.44 million in Q4 2024, then to US$570.49 million in Q1 2025 and US$645.98 million in Q4 2025. Basic EPS shifted from a loss of US$3.40 in Q3 2024 to a...

Viper Energy Q1 2026 earnings snapshot Viper Energy (VNOM) opened Q1 2026 with mixed signals, as trailing twelve month revenue sat at US$1.3 billion against a loss of US$69 million, translating into trailing EPS of US$0.48. The most recent quarterly print in Q4 2025 showed revenue of US$411 million and a net loss of US$103 million, or EPS of US$0.61. Over the past few reported quarters, revenue has moved from US$232 million in Q1 2025 to US$283 million in Q2 2025, US$399 million in Q3 2025...

In April 2026, Daily Racing Form, a subsidiary of Affinity Interactive, announced multi-year exclusive print distribution agreements with American Wagering and Boyd Gaming, making it the sole provider of racing publications across key Las Vegas casinos including Boyd’s Gold Coast, Orleans and Sam’s Town properties. The tie-up deepens Boyd Gaming’s connection to core racing customers ahead of marquee events such as the Kentucky Derby, while aligning with Apex Hospitality’s broader push to...

Investors may be wondering whether Oppenheimer Holdings at around US$99 a share still offers value, or if most of the opportunity has already been priced in. The stock has been volatile recently, with an 11.3% pullback over the last 7 days alongside a 9.3% gain over 30 days, and returns of 36.8% year to date and 69.4% over the past year. Recent headlines around capital markets activity and trading conditions have kept investor attention on brokers and financial services stocks, including...

If you are wondering whether HP's current share price reflects its real value, you are not alone. This article walks through what the latest data says about where the stock stands today. HP shares last closed at US$21.15, with recent returns of 7.2% over 7 days and 8.4% over 30 days, but a 4.4% decline year to date and a 13.3% decline over 1 year. This frames an important question about whether the recent rebound changes the risk and reward trade off. Recent news coverage has focused on HP's...

If you are wondering whether Weatherford International at around US$108.61 is still offering value after its run, this breakdown will help you see what the current price really reflects. The stock has seen a 14.0% gain over the last 30 days and a 34.3% return year to date, while the 1 year return sits at 151.7% despite a 1.5% decline over the past week. Recent news around Weatherford International has focused on its position within the broader energy services sector and how investors are...

Why VeriSign’s latest earnings, guidance and dividend matter for investors VeriSign (VRSN) has drawn fresh attention after reporting first quarter 2026 results alongside updated full year guidance and a Board approved cash dividend, giving investors several new data points to assess. See our latest analysis for VeriSign. The earnings beat, fresh 2026 guidance and the approved US$0.81 dividend have coincided with firmer sentiment, with a 30 day share price return of 6.13% and a 14.65% year to...

XCF Global (SAFX) has drawn fresh attention after a series of updates, including a Q1 2026 operational briefing, a business combination agreement, a forbearance deal with lender Twain, and a sector conference appearance. See our latest analysis for XCF Global. Recent updates around the Reno facility restart, the business combination agreement, and the Twain forbearance deal have coincided with a sharp shift in sentiment, with a 90 day share price return of 166.1% but a 3 year total...

The market for SuperCom Ltd.'s ( NASDAQ:SPCB ) stock was strong after it released a healthy earnings report last week...

Readers hoping to buy Lazard, Inc. ( NYSE:LAZ ) for its dividend will need to make their move shortly, as the stock is...

United Therapeutics Corporation has already reported first-quarter 2026 results, with sales of US$781.5 million and net income of US$274.9 million, both lower than the same period last year and below analyst expectations. The earnings shortfall contrasts with earlier optimism driven by positive ralinepag Phase 3 data and pipeline milestones in pulmonary disease and organ technologies, sharpening investor focus on how reliably current products can fund future innovation. Against this backdrop...

In April 2026, Guardant Health announced a multi-year collaboration with Nuvalent to use its Guardant Infinity platform’s tissue and liquid biopsy tests in supporting Nuvalent’s global oncology trials and potential commercialization efforts. This alliance highlights how pairing Nuvalent’s kinase-targeted cancer therapies with Guardant’s precision diagnostics could tighten patient selection, streamline regulatory pathways, and strengthen future companion diagnostic strategies. Next, we’ll...